Page last updated: 2024-08-22

sulfadoxine and Urinary Tract Infections

sulfadoxine has been researched along with Urinary Tract Infections in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Nathanson, BH; Shorr, AF; Sulham, K; Zilberberg, MD1
Cheong, HJ; Cho, YK; Choi, TY; Chung, MH; Kang, JO; Ki, M; Kim, J; Kim, SJ; Kim, Y; Kwon, KT; Lee, H; Lee, JS; Lim, SK; Pai, H; Park, DW; Ryu, SY; Seo, MR; Wie, SH1
Beerepoot, MA; de Borgie, CA; de Reijke, TM; Geerlings, SE; Koeijers, J; Nys, S; Prins, JM; Stobberingh, E; ter Riet, G; van der Wal, WM; Verbon, A1
BERGMANN, M; HIEGER, W; ZANGER, J1

Trials

1 trial(s) available for sulfadoxine and Urinary Tract Infections

ArticleYear
Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women.
    Archives of internal medicine, 2012, May-14, Volume: 172, Issue:9

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Double-Blind Method; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Lactobacillus; Middle Aged; Postmenopause; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections; Urine

2012

Other Studies

3 other study(ies) available for sulfadoxine and Urinary Tract Infections

ArticleYear
Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013-2018: a retrospective cohort study.
    BMC infectious diseases, 2021, Feb-08, Volume: 21, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Chronic Disease; Drug Combinations; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Sulfadoxine; Trimethoprim; United States; Urinary Tract Infections

2021
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea.
    Journal of Korean medical science, 2014, Volume: 29, Issue:8

    Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Nitrofurantoin; Penicillins; Republic of Korea; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections

2014
[Clinical experiences in the treatment of urinary tract infections with the long acting sulfonamide Ro 4-4393].
    Zeitschrift fur Urologie, 1963, Volume: 56

    Topics: Humans; Immunotherapy, Adoptive; Sulfadoxine; Sulfanilamide; Sulfanilamides; Sulfonamides; Urinary Tract Infections

1963